Metabolic disorders are complex abnormalities involving impaired glucose and lipid metabolism, associated with complications such as kidney disease, cardiovascular foot ulcer, retinopathy, neuropathy [...]

Lipid disorders are highly heterogeneous and widely prevalent throughout the world. Dyslipidemia is an important risk factor for atherosclerotic disease and its clinical sequelae, including myocardial infarction, ischemic stroke, and death. The impact of dyslipidemia treatment on risk for cardiovascular disease is one of the most intensively studied issues in all of medicine. This volume is an ...

Lipid disorders are highly heterogeneous and widely prevalent throughout the world. Dyslipidemia is an important risk factor for atherosclerotic disease and its clinical sequelae, including myocardial infarction, ischemic stroke, and death. The impact of dyslipidemia treatment on risk for cardiovascular disease is one of the most intensively studied issues in all of medicine. This volume is an ...

The incidence of fasting HLP in 326 diabetics was 68.4 percent. The common types of HLP were type IV, IIb, IIa and III respectively. There was one case of type V. HDLC was decreased in all three groups of diabetics together with elevated ratio of TC to HDLC comparing with the controls of similar age and sex VLDL and TG were significantly elevated in NIDDM aged 60 and over comparing with IDDM bu...

Lipid disorders are associated with atherosclerotic vascular disease, and therapy is associated with a substantial reduction in cardiovascular events. Current approaches to the treatment of lipid disorders are ineffective in a substantial number of patients. New therapies for refractory hypercholesterolemia, severe hypertriglyceridemia, and low levels of high-density lipoprotein cholesterol are...

Lipid disorders are highly heterogeneous and widely prevalent throughout the world. Dyslipidemia is an important risk factor for atherosclerotic disease and its clinical sequelae, including myocardial infarction, ischemic stroke, and death. The impact of dyslipidemia treatment on risk for cardiovascular disease is one of the most intensively studied issues in all of medicine. This volume is an ...

Lipid disorders are highly heterogeneous and widely prevalent throughout the world. Dyslipidemia is an important risk factor for atherosclerotic disease and its clinical sequelae, including myocardial infarction, ischemic stroke, and death. The impact of dyslipidemia treatment on risk for cardiovascular disease is one of the most intensively studied issues in all of medicine. This volume is an ...